非小細(xì)胞肺癌是威脅人類健康的重大疾病之一,目前尚缺乏根本的治療方法。中藥因具有整體治療、有效提高患者生存質(zhì)量和生存期等顯著特點(diǎn),在臨床上治療非小細(xì)胞肺癌,無論是與手術(shù)治療、化學(xué)藥物治療、放射性治療等聯(lián)合使用,還是晚期非小細(xì)胞肺癌的維持治療等方面均得到了廣泛的應(yīng)用。對(duì)近年來中藥治療非小細(xì)胞肺癌的臨床應(yīng)用及其抗腫瘤作用機(jī)制進(jìn)行了概述,以期為中藥治療腫瘤的臨床應(yīng)用和中藥抗癌新藥的研發(fā)提供借鑒。

Non-small cell lung cancer (NSCLC) has become one of the major diseases threatening to human health. In recently years, there are no fundamental clinical treatment methods for treating it. Owing to many prominent characteristics, such as holistic therapy, improving the life quality and overall survival of the patients, Chinese materia medica (CMM) have been widely applied in clinic treatment of NSCLC. This article outlined the clinical application and antitumor mechanism of CMM in treatment of NSCLC, which was looking forward to provide reference for the research and development of novel traditional Chinese medicine.

天津市科技支撐計(jì)劃(2ZCDZSY19100)